Value Microcaps Zip Code Changers

[Potse]

TEEE(.074)...accumulated more shares today.....

5.85M shares outstanding
$526K market cap
A 1:14.62 reverse split is expected in the next week or so.

Picked up a few more shares of the TEEE shell. All significant debt/liabilities appear to have been resolved now, with conversions into common stock generally in the 4-7 cent area (including shares issued to the shell's CEO, who will remain a Director with the new company).

The valuation of the shell under the 10-cent area still seems reasonable to me prior to the entry into a RM deal. Although there is quite a bit of risk involved here since I don't know what the financials and balance sheet of the RM target(s) look like, or what the final share structure will look like, I think there is a chance this stock might become an interesting low float and/or momentum play at some point after the reverse merger. Following the reverse split and the first part of the RM transaction, it appears that the tradeable float on this stock could be as low as 250K for awhile.

Picked up some more shares of the TEEE shell today at .072/shr. There was a brief derailment of the reverse merger in 2013, but now it appears the RM is back on track (with one modification, which eliminates the acquisition of PharmHouse Pharmacy) and will probably close sometime during the next quarter or two.

As I mentioned in the above post, this should develop into a potentially very interesting low float situation following the reverse split and RM acquisition. Outstanding share count after the RM will be 4M shares. The float should be extremely tight for quite awhile, and momentum players will probably be able to move the stock with relative ease.

As far as I am aware, I believe this is the first company that Alan Meeker (Chairman of Fuse Medical) will have brought public. I think most of Meeker's wealth has been obtained through his oil/gas investments, but he has become somewhat "famous" in the last couple/few years for his involvement in cloning race/polo horses through his Crestview Genetics company.

The "physician-owned distributorship" business model of Fuse Medical has come under increased government scrutiny recently, resulting in more complex compliance issues for companies like Fuse. But the fact that Meeker/Fuse seem comfortable in bring the company public would suggest to me that they are confident that the current business strategy (or any planned acquisitions or changes/expansion of the company's business directions) will be successful in the current market.

I think this version of the RM has a strong possibilty of closing, since Fuse Medical made the following statement in a job posting last week.....

Office Manager to perform office management duties as well as Executive Assistant duties to a medical device sales company. The company is currently experiencing rapid growth and is in the midst of going public. Skill set must include understanding of hospital/ASC billing and or codes, coordination with manufacturers for product supply, coordination for executive team's calendar and travel. filing, account maintenance and customer service work

http://www.careerbuilder.com/JobSeeker/Jobs/JobDetails.aspx?SiteID=cbaolfindajob&showNewJDP=yes&Job_DID=JHT4GC6173QQLK5X56H